Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01682083 |
|---|---|
| Brief Title: | Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). (COMBI-AD) |
| First Submitted : | September 6, 2012 |
| First Submitted that Met QC Criteria : | September 7, 2012 |
| First Posted : | September 10, 2012 (Estimate) |
| Results First Submitted : | May 29, 2018 |
| Results First Submitted that Met QC Criteria : | August 28, 2018 |
| Results First Posted : | September 26, 2018 |
| Certification/Extension First Submitted : | March 30, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | March 30, 2018 |
| Certification/Extension First Posted : | April 3, 2018 |
| Last Update Submitted that Met QC Criteria : | August 16, 2023 |
| Last Update Posted : | August 30, 2023 |